A normative analytic framework for development of practice guidelines for specific clinical populations

Medical Decision Making

Volumn 17, Issue 4, 1997, Pages 409-426

  Owens, Douglas K ^a   Nease, Robert F ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Cost effectiveness; Decision models; Practice guidelines; Site specific guidelines

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; POPULATION RESEARCH; PRACTICE GUIDELINE; SOCIOECONOMICS; VIRUS INFECTION;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MARKOV CHAINS; MASS SCREENING; MODELS, ECONOMETRIC; PRACTICE GUIDELINES; QUALITY-ADJUSTED LIFE YEARS;

EID: 0030797776     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9701700406     Document Type: Article

References (56)

1. Garber AM, Littenberg B, Sox HC, Wagner JL, Gluck M. Costs and health consequences of cholesterol screening for asymptomatic older Americans. Arch Intern Med. 1991;151:1089-95.
2. Garber AM, Wagner JL. Practice guidelines and cholesterol policy. Health Aff. 1991;10:52-66.
3. Owens DK, Nease RF, Harris RA. Cost - effectiveness of HIV screening in acute care settings. Arch Intern Med. 1996;156:394-404.
4. Field MJ, Lohr KN (eds). Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press, 1990.
5. Estes EH, Sullivan RJ. Standards for practice. Effectiveness and acceptance. Ann Intern Med. 1978;89:826-8.
6. Fletcher RH, Fletcher SW. Clinical practice guidelines. Ann Intern Med. 1990;113:645-6.
7. Audet A, Greenfield S, Field M. Medical practice guidelines: current activities and future directions. Ann Intern Med. 1990;113:709-14.
8. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321:1306-11.
9. Young M, McMahon L, Stress J. Prediction rules for patients with suspected myocardial infarction. Applying guidelines in community hospitals. Arch Intern Med. 1987;147:1219-22.
10. Eddy DM. Practice policies - guidelines for methods. JAMA. 1990;263:1839-41.
11. Eddy DM. Guidelines for policy statements. The explicit approach. JAMA. 1990;263:2239-43.
12. Eddy DM. Designing a practice policy. Standards, guidelines, and options. JAMA. 1990;263:3077-84.
13. Owens DK, Harris RA, Scott PM, Nease RF. Screening surgeons for human immunodeficiency virus (HIV): a cost - effectiveness analysis. Ann Intern Med. 1995;122:641-52.
14. Owens DK, Nease RF. Transmission of human immunodeficiency virus (HIV) infection between physicians and patients: a model-based analysis of risk. In: Kaplan E, Brandeau ML (eds). Modeling the AIDS Epidemic: Planning, Policy, and Prediction. New York: Raven Press, 1994:153-77.
15. St. Louis M, Rauch KJ, Petersen LR, Anderson JE, Sellable CA, Dondero TJ. Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. The Sentinel Hospital Surveillance Group. N Engl J. Med. 1990;323:213-8.
16. Laupacis A, Feeny D, Detsky A, Tugwell P. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J. 1992;146:473-81.
17. Laupacis A, Feeny D, Detsky A, Tugwell P. Tentative guidelines for using clinical and economic evaluations revisited. Can Med Assoc J. 1993;148:927-9.
18. Naylor C, Williams J, Basinski A, Goel V. Technology assessment and cost - effectiveness analysis: misguided guidelines? Can Med Assoc J. 1993;148:921-4.
19. Gafni A, Birch S. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Can Med Assoc J. 1993;148:913-7.
20. Howard RA. Information value theory. IEEE Transactions on Systems Science and Cybernetics. 1966;SSC-2:22-6.
21. Howard RA. Value of information lotteries. IEEE Transactions on Systems Science and Cybernetics. 1967;SSC-3:54-60.
22. Howard R. Decision analysis. Practice and promise. Management Science. 1988;34:679-95.
23. St. Louis ME, Olivo N, Critchley S, et al. Methods of surveillance for HIV infection at U.S. sentinel hospitals. Public Health Rep. 1990;105:140-6.
24. Nease RF, Owens DK. A method for estimating the cost - effectiveness of incorporating patient preferences into practice guidelines. Med Decis Making. 1994;14:382-92.
25. Owens DK, Nease RF. Development of outcome-based practice guidelines: a method for structuring problems and synthesizing evidence. Joint Commission Journal on Quality Im- provement. 1993;19:248-63.
26. Owens DK, Nease RF. A model-based approach for prioritizing information acquisition during guideline development [abstr]. Med Decis Making. 1991;11:330.
27. Nease RF, Owens DK. Decision models as an aid to short-term evaluation of clinical guidelines [abstr]. Med Decis Making. 1991;11:325.
28. Schapira MM, Matchar DB, Young MJ. The effectiveness of ovarian cancer screening. A decision analysis model. Ann Intern Med. 1993;118:838-43.
29. Carlson, KJ, Skates SJ, Singer DE, Screening for ovarian cancer. Ann Intern Med. 1994;121:124-32.
30. American College of Physicians. Screening for ovarian cancer, recommendations and rationale. Ann Intern Med. 1994;121:141-2.
31. Eddy DM. Screening for breast cancer. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:229-54.
32. Eddy DM. Screening for lung cancer. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:312-25.
33. Eddy DM. Screening for cervical cancer. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:255-85.
34. Fahs MC, Mandelblatt J, Schechter C, Muller C. Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med. 1992;117:520-7.
35. Eddy DM. Screening for colorectal cancer. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:286-311.
36. Melton JL, III, Eddy DM, Johnston CC. Screening for osteoporosis. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:202-28.
37. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-37.
38. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med. 1992;117:1038-41.
39. Littenberg B, Garber AM, Sox HC Jr. Screening for hypertension. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:22-46.
40. Singer DE, Samet JH, Coley CM, Nathan DM. Screening for diabetes mellitus. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:154-78.
41. Sox HC Jr, Littenberg B, Garber AM. The role of exercise testing in screening for coronary artery disease. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:81-112.
42. Sox HC Jr, Garber AM, Littenberg B. The resting electrocardiogram as a screening test: a clinical analysis. In: Eddy DM (ed). Common Screening Tests. Philadelphia, PA: American College of Physicians, 1991:47-80.
43. Wood FW. An American Profile - Opinions and Behavior, 1972-1989. Detroit, MI: Gale Research, 1990.
44. Hunt AJ, Davies PM, Weatherburn P, Coxon AP, McManus TJ. Sexual partners, penetrative sexual partners and HIV risk. AIDS. 1991;5:723-8.
45. Smith TW. Adult sexual behavior in 1989: number of partners, frequency of intercourse and risk of AIDS. Fa, Plann Perspect. 1991;23:102-7.
46. Billy JO, Tanfer, K, Grady WR, Klrpinger DH. The sexual behavior of men in the United States. Fam Plann Perspect. 1993;25:52-60.
47. DeBuono BA, Zinner SH, Daamen M, McCormack WM. Sexual behavior of college women in 1975, 1986, and 1989. N Engl J. Med. 1990;322:821-5.
48. Forman D, Chilvers C. Sexual behaviour of young and middle aged men in England and Wales. Br Med J. 1989;298:1137-42.
49. Wenger NS, Linn LS, Epstein M, Shapiro MF. Reduction of high-risk sexual behavior among heterosexuals undergoing HIV antibody testing: a randomized clinical trial. Am J Public Health. 1991;81:1580-5.
50. Kamenga M. Condom use and associated HIV soroconversion following intensive HIV counseling of 122 married couples in Zaire with discordant HIV serology. Proceedings and Abstracts of the Fifth International Conference on AIDS, June 4-9, 1989. Montreal, Quebec: International Development Research Centre, Health and Welfare Canada, and the World Health Organization, 1989:703.
51. Calsyn DA, Saxon AJ, Freeman GJ, Whittaker S. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health. 1992;82:573-5.
52. Wenger NS, Greenberg JM, Hilborne LH, Kusseling F, Mangotich M, Shapiro MF. Effect of HIV antibody testing and AIDS education on communication about HIV risk and sexual behavior: a randomized, controlled trial in college students. Ann Intern Med. 1992;117:905-11.
53. McCusker J, Stoddard AM, Mayer KH, Zapka J, Morrison C, Saltzman SP. Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men. Am J Public Health. 1988;78:462-7.
54. Lindan C. HIV testing and education promote safer sex among urban women in Rwanda. Proceedings and Abstracts of the Sixth International Conference on AIDS, June 20-24, 1990. San Francisco, CA: University of California, 1990:256.
55. Sononstein FL, Pleck JH, Ku LC. Sexual activity, condom use and AIDS awareness among adolescent males. Fam Plann Perspect. 1989;21:152-8.
56. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA. 1991:266:2419-29.